Replimune Announces Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

NEXT STORY
Celldex Therapeutics Announces Upcoming Data Presentations
PREV STORY
VitalHub to Present at StableView TECH19 Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biogen Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients

author_avatar
NASDAQ Market News

Cesca Therapeutics Inc. to Present at the 8th Spring Meeting of the International Society for BioProcess Technology (ISBiotech)

RANCHO CORDOVA, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) ...

author_avatar
NASDAQ Market News

Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery

author_avatar
NASDAQ Market News